Discovery could explain widespread acquired resistance among patients treated with immune checkpoint blockade drugs. T-cells attacking a cancer cell. Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination...